BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16735697)

  • 1. Erlotinib induced skin rash spares skin in previous radiotherapy field.
    Mitra SS; Simcock R
    J Clin Oncol; 2006 Jun; 24(16):e28-9. PubMed ID: 16735697
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiation-induced prevention of erlotinib-induced skin rash is transient: a new aspect toward the understanding of epidermal growth factor receptor inhibitor associated cutaneous adverse effects.
    Gerber PA; Enderlein E; Homey B; Muller A; Boelke E; Budach W
    J Clin Oncol; 2007 Oct; 25(29):4697-8; author reply 4698-9. PubMed ID: 17925571
    [No Abstract]   [Full Text] [Related]  

  • 3. Erlotinib-induced generalized eczema craquelé and follicular rash sparing the previous radiation field.
    Chiu HY; Cheng YP; Jee SH; Tsai TF
    Clin Exp Dermatol; 2012 Dec; 37(8):922-4. PubMed ID: 22731795
    [No Abstract]   [Full Text] [Related]  

  • 4. Folliculitis-perifolliculitis related to erlotinib therapy spares previously irradiated skin.
    Acharya J; Lyon C; Bottomley DM
    J Am Acad Dermatol; 2009 Jan; 60(1):154-7. PubMed ID: 19103369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erlotinib-induced rash spares previously irradiated skin.
    Lips IM; Koster ME; Houwing RH; Vonk EJ
    Strahlenther Onkol; 2011 Aug; 187(8):499-501. PubMed ID: 21789741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of bullous dermatitis induced by erlotinib.
    Oteri A; Cattaneo MT; Filipazzi V; Ferrario S; Gambaro A; Isabella L; Tosca N; Clementi E; Radice S; Piazza E
    Oncologist; 2009 Dec; 14(12):1201-4. PubMed ID: 19965913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spared pre-irradiated area in pustular lesions induced by icotinib showing decreased expressions of CD1a+ langerhans cells and FGFR2.
    Zhao Q; Wang YN; Wang B
    Jpn J Clin Oncol; 2013 Feb; 43(2):200-4. PubMed ID: 23264674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A man whose scapula was spared a drug-associated rash.
    Sanz A; del Valle ML
    CMAJ; 2005 Mar; 172(6):745. PubMed ID: 15767607
    [No Abstract]   [Full Text] [Related]  

  • 9. Purpuric drug eruption and alopecia induced by erlotinib.
    Nakamura-Wakatsuki T; Yamamoto T
    Dermatol Online J; 2012 May; 18(5):16. PubMed ID: 22630586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of G-CSF-producing invasive apical cancer resected following preoperative adjuvant therapy.
    Takagi Y; Nakamura H; Miwa K; Adachi Y; Fujioka S; Haruki T; Taniguchi Y
    Thorac Cardiovasc Surg; 2010 Aug; 58(5):304-6. PubMed ID: 20680910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hand-foot syndrome and seborrheic dermatitis-like eruption induced by erlotinib.
    Benomar S; Boutayeb S; Afifi Y; Hamada S; Bouhllab J; Hassam B; Errihanni H
    Dermatol Online J; 2009 Nov; 15(11):2. PubMed ID: 19951638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after salvage surgery for colorectal lung metastases.
    Presicci PF; Veronesi G; D'Aiuto M; Spaggiari L
    Ann Thorac Surg; 2005 Jan; 79(1):325-6. PubMed ID: 15620970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unilateral degeneration of tissue of the tonsil in a patient with adeno-carcinoma of the lung].
    Sommer F; Rettinger G; Kastl K
    Laryngorhinootologie; 2011 Jan; 90(1):30-1. PubMed ID: 20714988
    [No Abstract]   [Full Text] [Related]  

  • 14. Lung cancer and its operable brain metastasis: survival rate and staging problems.
    Furák J; Troján I; Szöke T; Agócs L; Csekeö A; Kas J; Svastics E; Eller J; Tiszlavicz L
    Ann Thorac Surg; 2005 Jan; 79(1):241-7; discussion 241-7. PubMed ID: 15620950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor.
    Eames T; Landthaler M; Karrer S
    Eur J Dermatol; 2007; 17(6):552-3. PubMed ID: 17951151
    [No Abstract]   [Full Text] [Related]  

  • 16. Trichomegaly induced by erlotinib.
    Papadopoulos R; Chasapi V; Bachariou A
    Orbit; 2008; 27(4):329-30. PubMed ID: 18716976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sparing of previously irradiated skin from erlotinib-induced acneiform rash.
    Yalçin S; Dizdar O; Yalçin B; Gököz O
    J Am Acad Dermatol; 2008 Jan; 58(1):178-9. PubMed ID: 18158935
    [No Abstract]   [Full Text] [Related]  

  • 18. Rosaceiform eruption induced by erlotinib.
    Patrizi A; Bianchi F; Neri I
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S43-5. PubMed ID: 18837734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The theoretical foundation and research progress for WBRT combined with erlotinib for the treatment of multiple brain metastases in patients with lung adenocarcinoma.
    Zhuang H; Wang J; Zhao L; Yuan Z; Wang P
    Int J Cancer; 2013 Nov; 133(10):2277-83. PubMed ID: 23720067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erlotinib-induced hair repigmentation.
    Cheng YP; Chen HJ; Chiu HC
    Int J Dermatol; 2014 Jan; 53(1):e55-7. PubMed ID: 23432346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.